Member Info for CHELSEA7

11/07/2018 11:34 4,000 12.28
11/07/2018 11:25 1,538 12.28
11/07/2018 09:43 24,529 12.23
11/07/2018 08:01 15,000 12.23
11/07/2018 08:00 2,000 12.23

At 12.25, black trade at 12.25

Keiny, been saying the same thing, and took a lot of grief for saying it.

From CH"s reply it sounded pretty close for news of the IND, but yes cloak and dagger now. I really think us PI"s deserve a better newsflow.

Hi chester, it was posted up yesterday on NEX. GL...................................

10/07/2018 09:36 70,000 12.4

From 10.00 at 12.2637...................................action stations!!!

12.2/12.3

58k from 9.12 at 11.8463!!!

Wonder how tight Panmure are sitting on 12.2??

12.2/12.5

Morning All, growing older and still waiting for Scancell to pop. Enjoying this BB as much as ever, best regards and wishes to all.

Another from goosed, an avid reader of Sugarcone, a good read...........................................

http://www.sugarconebiotech.com/?p=1079

Here"s hoping for a 300k+ day here, and a miracle tonight. Have a good day guys.

gooosed9 Jul '18 - 14:12 - 16590 of 16603
0 1 0
Current licensing deal with Ichor runs out this week - so perhaps some news really is due.

Then again it was "reasonable to expect" news in H1 2018 re "commercial & other" not to mention the Left Field news & of course the AGM comment about all Holloway having to do was spend it.

Biotech time seems to be based in another dimension - an alternate universe.

Volume picking up...........................yesterday 220k...........................buys....................212k

Remember today....................................

More
One week to go til our July 11th, webinar, on the topic of funding your biotech breakthrough. Joining us will be John Glencross of @CalculusCapital , Oliver Sexton of @Midven and Michael Kipping from @innovateuk

Have you signed up yet?

https://bia.me/2IDqfGL

Seems as relevant now. Thanks to richardgdawson for the thread..........................................

http://uk.advfn.com/cmn/fbb/thread.php3?id=28007005&from=2989&to=2989

Wins are off the bid at 12.2, leaving just Panmure alone.

Delayed trade to come?

10/07/2018 14:59 23,809 12.55
10/07/2018 14:21 7,951 12.23

Buys 149k

Sells 8k

The comeback is on? IMHO

https://www.fiercebiotech.com/research/one-step-closer-to-personalized-treatments-for-bladder-cancer?mkt_tok=eyJpIjoiT0RkbE5EQm1NVEl6TkdGayIsInQiOiJFT1lBK1JiRWc0SFdkQXBFbnk5VFVSXC9KNWRXMGFUeTVIZWw3OTJSaklSRzhDMGtEMmhhVjFQVmZqKzE0TmNDRHpXc0hMMEVSenZBYytta0pKdkEzaWh3YkFTUzZaUFRwSGVibnVrdnRIOStuR0xWRG9uY1g5WjlQQVczbzlWaTEifQ%3D%3D&mrkid=36433381

https://www.fiercebiotech.com/research/torque-s-t-cell-backpacks-boost-immune-attack-against-solid-tumors-mice?mkt_tok=eyJpIjoiT0RkbE5EQm1NVEl6TkdGayIsInQiOiJFT1lBK1JiRWc0SFdkQXBFbnk5VFVSXC9KNWRXMGFUeTVIZWw3OTJSaklSRzhDMGtEMmhhVjFQVmZqKzE0TmNDRHpXc0hMMEVSenZBYytta0pKdkEzaWh3YkFTUzZaUFRwSGVibnVrdnRIOStuR0xWRG9uY1g5WjlQQVczbzlWaTEifQ%3D%3D&mrkid=36433381

Thanks Timbo. It must have been back in 2016 I met you at the OXT AGM, with Krafty.

I thought RG cut a lonely figure that day. After quite a shortened presentation, he sat alone, talking to nobody. It was their I struck a fairly long conversation with him, after tempting him to a couple of buffet plates. I spent the rest of time talking to OXT"s R.Goodfellow.

For those going, a very welcoming BOD, excellent buffet, and would be interested to hear about the presentation and OXT"s current attitude to SCLP SP. They certainly weren"t that happy then. ATB

From the "left field"...........................................

https://endpts.com/help-wanted-ceo-to-run-a-330m-fund-in-search-of-breakthrough-biotech-ideas/?utm_medium=email&utm_campaign=Tuesday%20July%2010%202018&utm_content=Tuesday%20July%2010%202018+CID_57d083f213a54f50ad3605ef508c6bab&utm_source=ENDPOINTS%20emails&utm_term=Help%20wanted%20CEO%20to%20run%20a%20330M%20fund%20in%20search%20of%20breakthrough%20biotech%20ideas

More on that GF, and further connections to Roche.......................................

https://www.thepharmaletter.com/article/biontech-and-genevant-partner-up-on-rare-diseases